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Abstract
Background: Many studies have been published about ethics committees and the clarifications requested about
the submitted applications. In Finland, ethics committees require a separate statement on ethical aspects of the
research in applications to the ethics committee. However, little is known about how researchers consider the
ethical aspects of their own studies.
Methods: The data were collected from all the applications received by the official regional ethics committee in
the Hospital District of Northern Savo during 2004–2009 (n = 688). These included a total of 56 studies involving
research on tissue other than blood. The statements by the researchers about the ethics about their own research
in these applications were analyzed by thematic content analysis under the following themes: recruitment,
informed consent, risks and benefits, confidentiality and societal meaning.
Results: The researchers tended to describe recruitment and informed consent process very briefly. Usually these
descriptions simply stated who the recruiter was and that written consent would be required. There was little
information provided on the recruitment situation and on how the study recruiters would be informed. Although
most of the studies were clinical, the possibility was hardly ever discussed that patients could fail to distinguish
between care and research.
Conclusion: The written guidelines, available on the webpages of the ethics committee, do not seem to be
enough to help researchers achieve this goal. In addition to detailed guidelines for researchers, investigators need
to be taught to appreciate the ethical aspects in their own studies.
Keywords: Thematic content analysis, Ethical views of scientists, Application to ethics committee, Informed
consent, Recruitment
Background
Incidents of questionable practices in human biomedical
research in the history have triggered the need for inter-
national regulations e.g. the Nuremberg Code in 1947
and later the Declaration of Helsinki in 1964. These de-
fine the ethical principles of medical research involving
human subjects. In the past decades, a number of regu-
lations about medical research have been issued at both
the international and national levels [1]. According to
the Declaration of Helsinki, a pre-evaluation of the re-
search plan should be performed by an independent re-
search ethics committee [1,2]. According to the current
Finnish legislation, five health care districts have official
research ethics committees that evaluate all biomedical
studies on humans and human tissues from an ethical
and legal perspective [3].
Studies investigating the process of ethical review have
revealed that most of the clarifications requested from
the researchers by the committees are concerned with
the informed consent process [4,5]. There may be other
causes for clarification requests e.g. failure to comply
with correct procedures, missing information and dis-
crepancies [6]. In studies on the evaluation process itself,
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the critical aspects have included the evaluation time [7],
a lack of uniformity in application forms and variations
in the approval procedures adopted by different commit-
tees within the same country [8,9].
Whitney and coworkers [10] focused on the opinions
of researchers about the functions of the Independent
Review Board (IRB) system. Their results indicated that
some scientists consider the IRB system to be cumber-
some by requiring completion of incomprehensible con-
sent forms that focus too much on details and which
seem to be intended to protect the institution rather
than the research subjects [10]. In addition, failure of
assessing risks and benefits, scientific validity and hand-
ling of consent procedures has been criticized by Paul
[11]. Taylor and coworkers suggested that one possibility
to speed up the evaluation process would be to invite
the principle investigator to attend the review meetings
[12]. Good communication between the scientists and
the ethics committee is critical if one wishes to achieve a
thorough consideration of all of the ethical aspects of re-
search. Prior attention should be paid beforehand to eth-
ical aspects if one wishes to guarantee the protection of
research participants as well as making sure that there
are no misunderstandings about the goals of the study
[12-14]. Education and training are also considered im-
portant for IRB members [15].
Several ethical aspects, especially those involving tissue
research, have been highlighted in the literature.
Legislation about the use of human tissue in scientific
research is regarded as important [16,17] and not unex-
pectedly, informed consent and autonomy in all human
research are listed as central issues [17-20]. Today, the
challenges of data protection and good research govern-
ance are emerging with the development of large tissue
and gene banks [17]. Another example of a specific type
of tissue research is human placental perfusion studies
which have recently been under scrutiny from an ethical
point of view [20-23].
The purpose of this study was to evaluate the ethical
statements of principal investigators. Such statements
are required by the official Research Ethics Committee
of the Hospital district of Northern Savo. We limited
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submitted as an attachment to the application form. This
was intended to include the following topics: justification
for the research (including societal meaning), informed
concent process, voluntariness, and recruitment process,
whether any vulnerable groups (e.g. children or pregnant
women) would be included, confidentiality, and evaluation
of risks and benefits.
The data were manually collected by two authors (AH,
MV) from all the applications sent to the ethics committee
during the defined years (n = 688). Although the material
was collected by two researchers, the multidisciplinary re-
search group discussed the selected studies. Studies
planning to include only a blood sample, or tissue from
a deceased person were excluded. Altogether 56 cases
involving tissue research were available. Ethics commit-
tee guidelines listing the required documents are avail-
able in the Internet (www.kuh.fi; Table 1).
This research project received an administrative ap-
proval by the participating hospital. According to the
Finnish law [3] this type of study does not need the ap-
proval from an official research ethics committee. The
data was stored in a locked place and coded for
analysis.
Data analysis
Within the documents, the data were analyzed both
qualitatively and quantitatively according to five themes:
recruitment, informed consent, risk and benefits, confi-
dentiality and societal meaning of the research. The
statements were read by AH and meaningful concepts
and information were grouped under the selected
themes and a thematic content analysis was performed
[24,25]. If a theme was addressed even in one sentence,
this was included as a statement within the theme. Al-
though the material was analysed by one researcher, the
multidisciplinary research group discussed the results at
all stages of the analysis. The research group also
worked together in reviewing the conceptualisation
process and the selected concepts by confirming the val-
idity of the study [24,25]. The content of the themes
(Table 2) was formulated according to the literature [2]
and previous studies of our research group [20,22,23] as
well as taking into consideration the instructions of the
ethics committee.
Results
The selected cases represented different types of tissues,
e.g. cancerous tissue, placental tissue, fatty tissue, brain
and neurons, gynecological tissues and samples from the
gastrointestinal tract. All of the application forms from
the years 2004–2005 contained text about ethical aspects
of the research project. In addition, a separate statement
of research ethics was included in 8/24 of these state-
ments. In 2006–2009, after the new guidelines were
implemented by the ethics committee, all of the
researchers submitted a separate statement as required
in the guidelines.
There were differences in the contents of the state-
ments both when comparing the years 2004–2005 with
2006–2009, and between the statements within these
groups. In general, the statements varied from a simple
statement that the Declaration of Helsinki was taken
into account, to detailed descriptions of many aspects of
research ethics (Table 3).
Recruitment and informed consent
The recruitment situation was described in more than a
half (31/56) of all the studied statements (Table 3). On
the other hand, recruitment was addressed only in four
of the statements from the years 2004–2005 and gener-
ally only the study population was defined (e.g. dia-
betics). In the statements from the years 2006–2009,
the recruitment process was explained in 27/32 of the
statements and more information was given; e.g. about
the planned recruiters, recruitment situation and how
the recruiters would be informed. In 5/56 statements,
the researchers had actually considered that the recruit-
ment situation was sensitive and this fact was described
in detail. These five statements also included a plan to
include information about the life-situation of the re-
search participants during the recruitment. The rest of
the statements mentioned very briefly the plan for re-
cruitment and the informed consent process: who
would be doing the recruitment and how the informa-
tion was planned to be given to the participants. In most
cases (46/56), the recruitment was planned to take place
during clinical treatment e.g. surgery or birth. The planned
recruiters varied (nurses, physicians or researchers).
The informed consent process was described in 33 of
the 56 statements. In general, the most common de-
scription of the informed consent process stated that
there would be a request for written informed consent
and the possibility to refuse participation. Voluntariness
and the possibility to discontinue the research were
described in 6/56 statements. A total of 8/56 statements
mentioned that time would be given for the invited par-
ticipants to consider their decision. However, in most
cases, the actual time allocated for a decision was not
defined.
Handling and confidentiality of personal information
Handling and confidentiality of personal information
were described in 36/56 of the statements. Coding was
correctly explained in 29/56 and anonymization in 5/56.
In these cases, coding and anonymization were defined
in a way that allowed the reader to understand what the
author meant by these terms. However, in 3/56 state-
ments, the meaning of anonymity (no possibility to link
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data to a person) and coding was confused (as an ex-
ample “samples will be anonymized and coded”). In 28/
56 cases, there was information provided about which
individual would have the code key and in 18/56 it was
explained how the data would be stored.
Risks and benefits, and societal meaning of the research
Considerations about risks and benefits were written in
80.4 % of all the statements. In most of these cases, it was
stated that the tissue would be removed during a clinical
procedure. The authors often stated that therefore no risk
for research participants would be envisioned, and/or
mentioned that the tissue was regarded as waste. Add-
itional samples (a separate tissue sample, other samples,
e.g. blood) were, however, explained in detail and con-
sidered as an extra risk. On the other hand, in all cases,
the difference between research and care was left unex-
plained. Individual research participants in 11/56 cases
were informed that they would not gain any direct benefit
from tissue donation. However, the, scientists did state
that benefits would be conferred through certain other
factors, for instance by obtaining results of blood tests or
through health education. In some studies, this type of in-
formation was planned to be given to the potential partici-
pants in an information leaflet.
In their consideration of ethical aspects, four research-
ers mentioned the possibility of unexpected results and
how the research participants in such a case would be
given the best possible care. None of the statements
contained any consideration under the term “societal
meaning”. However, the following aspects mentioned by
the scientists could be regarded as belonging to this cat-
egory: 11/56 mentioned that one benefit would be the
development of new methods, and 13/56 referred to
benefits for public health care in general (e.g. clarifica-
tion of disease mechanisms providing possibilites for
preventive actions and better care).
Discussion
Although there have been publications on the ethical
aspects of tissue research, as far as we are aware, none
have so far handled the ethical statements of researchers.
The Research Ethics committee of Hospital District of
Northern Savo expects that a separate statement sheet
Table 2 Preconceived aspects from the literature within the themes [2,20,22,23]
The main aspects Contents sought out
 Recruitment  Situation at the time of the research
 The process of decision about participation
 How the information was planned to be given to recruiters
 Possible vulnerable groups
 Informed consent and voluntariness  How the information was planned to be given to invited participants
 Comprehension of written and oral information
 Voluntariness
 Appreciation of voluntariness
 Interaction between the recruiter and participants
 Risks and benefits of the research for participants  Meaning, significance and stressfulness of the research for the participants
 Purely research or within clinical care
 Handling and confidentiality of personal data  Confidentiality, concerns for preserving privacy
 Views about societal meaning  General justification of research
 Putative benefits for future
Table 3 Presence of ethical themes in the analyzed statements
Theme Years 2004–2005 (n = 24) Years 2006–2009 (n= 32) Total (n = 56)
No. (% of total) No. (% of total) No. (% of total)
Recruitment 4 (16.7) 27 (84.4) 31 (55.4)
Informed consent 9 (37.5) 24 (75.0) 33 (58.9)
Risks and benefits 16 (66.7) 29 (90.6) 45 (80.4)
Confidentiality 10 (41.7) 26 (81.3) 36 (64.3)
Societal meaning 6 (25.0) 13 (40.6) 19 (33.9)
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should be submitted to the research ethics committee.
One interesting and important point emerging from our
results was the insufficient handling of the key ethical
aspects in many of the applications for the research eth-
ics committee. On the other hand, only the official forms
and separate statements about ethical aspects were stud-
ied and it is possible that the research plan in some
cases included some of this information. It was evident
that, in general, the statements were less structured in
2004–2005 than in 2006–2009, when the ethics commit-
tee had already formulated the requirements for the eth-
ical statements and their content. Thus, in our case, the
formal requirement and advice by the ethics committee
had a positive effect on the quality of the written state-
ments. In the study by Antes and coworkers [26] it was
disturbing that in some cases the reasoning strategies,
such as awareness of the situation and consideration of
personal motivations, improved but at the same time
there was a decline in seeking help and considering
others' perspectives. Mentoring in research ethics is a
two-way road also with the possibility to both increase
and decrease ethically good conduct [27]. One postu-
lated way to improve ethics in biomedical research is to
conduct an ethics consultation with a bioethicist [28].
However, at present it is still unclear when, how and by
whom research ethics instruction would be most benefi-
cial. In addition, there needs to be a systematic study of
how such measures could affect the actual ethical con-
duct of researchers in addition to recognition and for-
mulation of ethical aspects and their handling in written
statements.
According to the general consensus, ethical considera-
tions should include details of the recruitment and
informed consent process with the following elements:
competence, voluntariness, understanding and consent
[1,2]. Still, only a few of the studied statements discussed
how competence and understanding would be ensured.
Voluntariness was usually mentioned very briefly in one
sentence. In our earlier studies [20,22,23] in accordance
with the literature [29], we have found the importance
of considering the actual situation when the signature is
being gained from the participant. In this study, the eth-
ical aspects about obtaining the signature for the con-
sent form were almost forgotten by the researchers, at
least according to their statements. Very few statements
mentioned how much time would be available for the
participant to make a decision. However, the time given
has been considered an important detail by many
authors [e.g. 13,30,31].
A major issue is how to educate the recruiters when
they are not part of the research group: how to inform
nurses/doctors about the research project in such a way
that they can provide relevant information to the partici-
pants [22,23]. This aspect was missing in most of the
statements, when the recruiter came from outside the
research group. Furthermore, there was a failure to ex-
plain the difference between patient care and research to
the patient. This so-called therapeutic misconception,
which means that the participant thinks that the study is
part of some clinical treatment, is a common situation
in practice [32,33]. To obtain a genuine informed con-
sent, these aspects should be discussed when planning
the research. Furthermore, in our previous studies
[20,22,23] and other authors [34,35] have observed that
even if planning is done carefully and information is
given to the recruiters, the recruitment in practice can
be very challenging.
The guidelines of the Ethics Committee of the Hos-
pital District of Northern Savo instruct researchers to
consider the justification for the research in their ethical
statements (Table 1). Furthermore, the Declaration of
Helsinki, as well as other regulations, requires that re-
search should be based on earlier literature and this
should be demonstrated in the research plan [1]. One of
the most important justifications for biomedical research
is its usefulness for patients and patient care in the form
of applicable knowledge for diagnostic, therapeutic and
prognostic purposes. Nonetheless, the studied state-
ments provided little information on the societal mean-
ing of the study. Similarly to confidentiality, societal
justification is a topic that may not be perceived as an
ethical aspect, and most likely it has been described in
the research plan.
It is unfortunate that the terminology in the literature
is confusing, for instance, the definitions of anonymity
and coding leave room for misunderstanding [13]. It is
clearly challenging to make the studies understandable
to lay people and such poorly defined details confuse
both researchers and the participants. Thus, the scien-
tific community should attempt to clarify the scientific
terminology, which actually may be regarded also as an
ethical requirement in human studies.
In future tissue research, it would be important to
study whether it makes a difference to the participants if
the tissue is removed simply for research purposes or if
it is leftover tissue from routine operations. In addition,
it would also be interesting to determine how people
perceive the difference between the situation of healthy
volunteers asked to donate to tissue banks compared to
the views of actual patients asked to donate left-over tis-
sue. Considering that this study was carried out in one
center only, we do not know the generalizability of our
results and comparison of investigations from different
centers would be helpful in further studies.
Conclusion
In conclusion, the justification of the research from an
ethical point of view was missing from the majority of
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the statements. It is noteworthy that even after the re-
quirement by the Ethics Committee for an ethical con-
sideration became mandatory, a significant percentage
of applications lacked considerations of recruitment,
informed consent and confidentiality. In view of the
rapid developments occurring in biomedicine, it is
clear that there is a need for continuing education in
research ethics. In addition, a dialogue between the
scientists and society would provide a better founda-
tion for scientists to take the societal aspects of their
research into account.
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